1. Home
  2. Labeler Index
  3. Qilu Antibiotics Pharmaceutical Co., Ltd.
  4. 51810-504
  5. NDC Package Code: 51810-504-02 Ertapenem

NDC Package 51810-504-02 Ertapenem

Ertapenem Sodium Injection, Powder, Lyophilized, For Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51810-504-02
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (51810-504-01)
Product Code:
51810-504
Proprietary Name:
Ertapenem
Non-Proprietary Name:
Ertapenem Sodium
Substance Name:
Ertapenem Sodium
Usage Information:
Ertapenem is used to prevent and treat a wide variety of bacterial infections. This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria.
11-Digit NDC Billing Format:
51810050402
Product Type:
Human Prescription Drug
Labeler Name:
Qilu Antibiotics Pharmaceutical Co., Ltd.
Dosage Form:
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
ERTAPENEM SODIUM 1 g/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA218067
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
10-31-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 51810-504-02?

The NDC Packaged Code 51810-504-02 is assigned to a package of 10 vial, single-dose in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial, single-dose (51810-504-01) of Ertapenem, a human prescription drug labeled by Qilu Antibiotics Pharmaceutical Co., Ltd.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular; intravenous form.

Is NDC 51810-504 included in the NDC Directory?

Yes, Ertapenem with product code 51810-504 is active and included in the NDC Directory. The product was first marketed by Qilu Antibiotics Pharmaceutical Co., Ltd. on October 31, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 51810-504-02?

The 11-digit format is 51810050402. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-251810-504-025-4-251810-0504-02